Goodwill And Other Intangible Assets

12 Months Ended

Dec. 31, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND OTHER INTANGIBLE ASSETS

The components of goodwill and other intangibles at December 31, 2014 and 2013, and related amortization periods for continuing operations are as follows:



(In Thousands)	2014		2013		Amortization Periods
Goodwill	$	169,687	$	172,788	Not amortized
Other identifiable intangibles:
Customer relationships (cost basis of $29,117 in 2014 and $31,357 in 2013)	21,620		25,962		10-12 years
Proprietary technology (cost basis of $18,228 in 2014 and $18,851 in 2013)	11,824		14,356		Not more than 15 years
Trade names	11,998		12,594		Indefinite life
Non-compete agreements (cost basis of $4,154 in 2014 and 2013)	—		600		2 years
Total carrying value of other intangibles	45,442		53,512
Total carrying value of goodwill and other intangibles	$	215,129	$	226,300

A reconciliation of the beginning and ending balance of goodwill for each of the three years in the period ended December 31, 2014 is as follows:



(In Thousands)	2014			2013			2012
Net carrying value of goodwill, beginning of year	$	172,788		$	176,620		$	165,372
Acquisitions	—			—			13,695
Increase (decrease) due to foreign currency translation	(3,101		)	(3,832		)	(2,447		)
Net carrying value of goodwill, end of year	$	169,687		$	172,788		$	176,620

At December 31, 2014, the goodwill balance was $156.0 million for Film Products and $13.7 million for Aluminum Extrusions.

Amortization expense for continuing operations over the next five years is expected to be as follows:



Year	Amount (In Thousands)
2015	$	4,741
2016	4,702
2017	4,702
2018	4,702
2019	4,568

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details